MedTrace Logo

Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis

NCT00315497 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 426

Last updated 2022-07-12

No results posted yet for this study

Summary

Giant cell arteritis (GCA), also known as temporal arteritis, is a disease that usually only occurs in older adults. GCA causes inflammation of blood vessels, or vasculitis. In order to properly treat this disease, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of disease in people with GCA.

Conditions

  • Temporal Arteritis

Sponsors & Collaborators

  • Office of Rare Diseases (ORD)

    collaborator NIH

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH

  • Rare Diseases Clinical Research Network

    collaborator NETWORK

  • University of Pennsylvania

    lead OTHER

Principal Investigators

  • Peter A. Merkel, MD, MPH · University of Pennsylvania

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00315497 on ClinicalTrials.gov